The role of CD32 during HIV-1 infection.

Persistence of latent HIV-1 in long-lived resting memory CD4+ T cells is a major barrier to curing HIV-1 infection, and thus a biomarker for latently infected cells would be of great scientific and clinical importance. Through an elegant discovery-based approach, Descours . reported that CD32a, an Fcγ receptor not normally expressed on T cells, is a potential biomarker for latently infected cells.

Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Background: Combination antiretroviral therapy (ART) has significantly increased survival among HIV-positive adults in the United States (U.S.) and Canada, but gains in life expectancy for this region have not been well characterized.